Kelly J. Clark MBA '07
Founder, Addiction Crisis Solutions
Board certified in both addiction medicine and psychiatry, Kelly J. Clark, MD, MBA, DFAPA, DFASAM is a practicing physician, business leader and recognized expert on issues related to substance misuse involving opioids as well as other illicit and prescription substances.
Considered one of the nation’s leading experts on substance use disorder and addiction care, she is frequently invited to testify about the disease of addiction and needed systems of treatment before Congress and to federal organizations and other drug policy stakeholders, including the United States Presidential Opioid Commission, Bipartisan Heroin and Opioid Task Force, the Food and Drug Administration (FDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Justice (DOJ) Civil Rights and Criminal Divisions, the Office of Comptroller General, the National Association of Attorneys General, the National Association for the Advancement of Science, Pew Trusts, National Safety Council, National Business Group on Health, American Psychiatric Association Foundation’s Judges and Psychiatrists Initiative, and the Council of State Governments’ Justice and Mental Health Collaboration Program.
Known for building consensus across diverse stakeholder groups, Dr. Clark works actively across the medical, scientific, criminal justice, and business communities to transform addiction care into evidence-based, cost-effective practice. Her approach to the U.S. drug crisis is summarized in her comments to the Presidential Opioid Commission: “We need to stop doing what we know doesn’t work and put our resources behind what we know does.” As Immediate Past President of the American Society of Addiction Medicine (ASAM), the national association that represents more than 6,500 addiction physician specialists and allied health professionals, she helped the organization lead bipartisan and multi-stakeholder coalitions to pass new legislation and policies, including the CARA, CURES, and SUPPORT Acts, as well as helping update HHS guidelines to allow expanded evidence-based treatment access. As Vice Chair of ASAM’s COVID-19 rapid-response task force, she has provided critical guidance to patients, providers, programs and policymakers on accessing addiction treatment during a global pandemic. As Chief Medical Officer for two multi-state outpatient treatment organizations in the US, she was instrumental in the growth of access to quality treatment for tens of thousands of patients in 14 states. As Behavioral Health Medical Director of CDPHP, a non-profit health insurance plan in New York, she helped guide the in-sourcing of behavioral health benefits, which improved the quality and value of care received by members by integrating physical and behavioral health teams. As Medical Director at CVS Caremark, Dr. Clark addressed issues such as the overutilization of controlled substances as well as decreased access to methamphetamine precursor substances in the retail pharmacy environment.
Dr. Clark’s experience spans emergency, acute, sub-acute, and chronic institutions; community, county, state, federal sites; and voluntary, involuntary, criminal justice and correctional settings. Working on Fraud, Waste and Abuse Teams, she targeted prescribers, retail pharmacies, and distributors engaging in aberrant behaviors, and currently uses these data analytic skills in a variety of criminal cases, primarily for the US Department of Justice. She has provided court testimony as an expert witness in federal district courts in Florida and Kentucky, as well as consulting on cases in multiple other jurisdictions on issues including sex and drug trafficking, health care fraud, and conspiracy to unlawfully distribute controlled substances. She served as faculty of the University of Massachusetts Medical School for eight years training students and resident physicians on the inpatient dual diagnosis unit as well as in outpatient, partial hospital, and consultative settings. She was founding faculty at the Virginia Tech Carilion School of Medicine, and she continues her work as a founding member of the National Rx Drug Abuse and Heroin Summit Advisory Board.
Dr. Clark serves as a leader in the National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic, and served as a contributing consultant to the recent “Opioids and the Workplace: An Employer Toolkit for Supporting Prevention, Treatment, and Recovery” with the Kentuckiana Health Collaborative, a member of the Network for Regional Healthcare Improvement and National Alliance of Healthcare Purchaser Coalitions. She is currently active on policy boards for several think tanks, organizations and innovative companies including the Milken Institute, ASAM, Dispose RX, Bicycle Health, and Path CCM.
Dr. Clark earned her Doctorate in Medicine from University of Wisconsin, Madison, WI; an MBA with Certificate in Health Sector Management from The Fuqua School of Business at Duke University, Durham, NC; and a BA in psychology from Coe College, Cedar Rapids, IA. She completed residency in psychiatry at the Medical College of Wisconsin.
What impact has your Fuqua experience had on your career/life?
Fuqua allowed me to gain the not only business knowledge and skill but also relationships with people who have meant much to me both personally and professionally over the years.
I sometimes joke that I am the only psychiatrist and addiction doc that most people will ever meet who has done graduate coursework in pharmaceutical marketing strategy…but since graduation I have worked with several pharmaceutical companies bringing medications to market. I never discount the usefulness of anything I learned at Fuqua!
Professionally or personally, what are you excited about right now?
As a country, we are at a moment where we can build the same evidence based, quality and value-conscious treatment system for addiction as we have for other medical conditions. The amount of collaboration that is required among sectors is significant, but these investments can directly address the enormous waste we have in the system. I am excited to help with the NAM Opioid Collaborative and the Milken Institute with this work, as well as with a number of innovative companies in this space.
What does this Fuqua alumni award mean to you?
It is a great honor to receive this award and to have been nominated by a former classmate. I’ve worked with several Team Fuqua members in different companies and projects since graduation – and I look forward to meeting other alumni and continuing to innovate and improve our health care system.
Kathy Baughman McLeod MBA '12
SVP & Director of the Adrienne Arsht-Rockefeller Foundation Resilience Center at the Atlantic Council
Kathy Baughman McLeod is a recognized global executive and expert on climate change and resilience with a track record of spearheading innovation for multinational organizations. A pioneer in the field of climate adaptation, she mobilizes expertise in policy, finance, conservation, risk and science, alongside proven leadership skills to deliver groundbreaking solutions.
As SVP and Director of the Adrienne Arsht-Rockefeller Foundation Resilience Center (Arsht-Rock) at the Atlantic Council, she leads creation and execution of the Center’s strategy to achieve its goal of reaching one billion people worldwide with resilience solutions to the challenges of climate impacts, migration, and human security by 2030. Under Kathy’s leadership, Arsht-Rock has launched the Extreme Heat Resilience Alliance with 40-plus public, private and non-profit leaders and scientists from every sector, and its initiative, City Champions for Heat Action. Three vanguard global mayors, representing Miami-Dade County, Florida, Freetown, Sierra Leone and Athens, Greece, have named the world’s first Chief Heat Officers, who will take action every day to protect almost five million people from the growing threat of extreme heat. The Center also launched an initiative to name and rank heatwaves, as has been done for tropical storms across the globe, to build awareness and a culture of preparation. Kathy is also a member of the executive management team of the Atlantic Council.
Kathy previously worked for Bank of America as SVP, Global Executive for Environmental and Social Risk where she led and executed Bank of America’s first global climate risk disclosure report in accordance with the Taskforce for Climate-related Financial Disclosures (TCFD). At The Nature Conservancy, as Global Managing Director for Climate Risk & Resilience, she developed the first-ever insurance product on a natural asset – a coral reef in Mexico - to reduce climate impacts and protect the reef and $10 billion coastal economy. The product and program were featured on the front page of The New York Times in December 2020. As Deputy Chief of Staff for the elected Treasurer/CFO of the State of Florida, Kathy launched the initiative that made the $30 billion Florida the first US State Treasury to publicly analyze and disclose climate risk.
Kathy is a member of the World Economic Forum’s Global Commission on “BiodiverCities by 2030” and a member of the Operating Committee of the Insurance Development Forum, a global public-private partnership including 17 companies with more than $435 billion AUM. She and her work have been featured in outlets including Foreign Affairs, The New Yorker, The New York Times, the Financial Times, NPR’s MarketPlace, MarketWatch, CBS News, Yahoo Finance, Aspen Ideas Festival, and the World Economic Forum. She is a regular speaker at and delegate to United Nations climate change and disaster risk platforms. Also a former Florida Energy & Climate Commissioner, Kathy has an MBA from Duke University’s Fuqua School of Business and an MS in Geography from Florida State University.
What impact has your Fuqua experience had on your career/life?
My Fuqua MBA gave me exactly what I sought - and needed - to make a critical pivot to work at the global scale. At Fuqua, I received a rigorous curriculum; high caliber credentials; a current, in-person view of the world, both culturally and through a business lens; and the gold standard of leadership training. Professor Allan Lind made an indelible mark on me, and I use his Delta Leadership Model with all my teams – I’m always striving for “contextual leadership,” one of the most challenging domains to achieve and maintain!
My Fuqua MBA allowed me to navigate my way to a role in global climate risk, resilience, and conservation finance - I know with 100% certainty that I wouldn’t be where I am now without my Fuqua education, experience and degree.
I am also well equipped for my current role as the Director of the Adrienne Arsht-Rockefeller Foundation Resilience Center at the Atlantic Council, where we need to move quickly and strategically on a multi-sector landscape. With a goal of reaching one billion people with resilience solutions to climate impacts, migration and human security by 2030 (www.onebillionresilient.org ), my Fuqua education gave me critical insights and skills.
Lastly, achieving my Fuqua MBA showed my daughters that women (and moms) can and should continue to advance themselves.
Professionally or personally, what are you excited about right now?
I am excited about all the inspiring women leaders I see and admire across all sectors! Christine Lagarde at the ECB, Kristalina Georgieva at the IMF, Vice President Kamala Harris, Jane Fraser, CEO at Citigroup, Jacinda Ardern, President of New Zealand, Tsai Ing-wen, President of Taiwan, Impact Philanthropist and Business Leader Adrienne Arsht, Yvonne Aki-Sawyerr OBE, the powerhouse Mayor of Freetown, Sierra Leone, climate-forward Mayors Anne Hidalgo of Paris and Daniella Levine Cava of Miami-Dade County, Greta Thunberg, Patricia Espinosa, President of the UN Climate Change Convention, Jennifer Morris, CEO of The Nature Conservancy – and many many more. What a refreshing new era of leadership, and just in time, as societies are struggling with multiple health, environmental, climate, economic and social crises. We will need the immense strength of female leaders to move us all toward what has be a more sustainable financial system and livable world.
The women in my class bonded quickly and we supported each other through the program, and those relationships made a huge difference. We still support each other – one of my closest friends generously nominated me for this award! I am also excited about lifting up female colleagues and women early in their careers, and working together to build a culture of empowerment, support and inclusion.
What does this Fuqua award mean to you?
I am humbled and extremely proud to be recognized with the Fuqua Alumni Association’s “Leader of Consequence” award! Before I had made a clear decision to pursue an MBA, I was a part of a Renewable Energy delegation to the UK Government and met someone from the GEMBA program at an energy trade show in London. After talking to Dan Vermeer there, I knew immediately that this was the program for me. The combination of the traditional MBA curriculum with a deep focus on leadership, the coursework that takes place around the world, discussions with regional business leaders and the exploration the critical cultural components of doing business in that market, made for a transformational experience for me, both professionally and personally.
Being recognized with this award validates me in two ways: first, it shows me that innovations like the creation of a new kind of insurance policy on a stretch of the Mesoamerican Reef in Quintana Roo, Mexico, has been acknowledged for its value and contribution to sustainable finance mechanisms. Second, it fuels me to continue pushing the boundaries at the intersection of finance, risk, nature, and climate for the protection of people and economies. We can survive and thrive in this beautiful, complicated world!
|2019-20||Warren Osborn MBA '99
Jessica Yinka Thomas MBA '04
TJ Abrams MBA '09
Brian Hamilton MBA '90
|2017-18||Allison Fansler MBA '06
Terry Tucker MBA '98
|2016-17||Tom Mitchell MBA '07
Peter Warlick MBA '94
|2015-16||Tim Jeffries MBA '03|
|2014-15||Alex Michalko MBA '10
Jeff Jablow MBA '05
|2013-14||John Troy MBA '09|
|2012-13||Paula Alexander MBA '98|
|2011-12||Paul Sansone MBA '92|